FDA Approved: SUNLENCA — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved Sunlenca (lenacapavir sodium) from Gilead Sciences as an original NDA. This marks the introduction of a new antiretroviral therapy for HIV-1 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SUNLENCA (LENACAPAVIR SODIUM)

Snippet

ORIG AP for SUNLENCA (LENACAPAVIR SODIUM)